© 2003 BMJ Publishing Group
LETTER
Moorens ulcer resolved with campath-1H
Department of Ophthalmology, Aberdeen Royal Infirmary, Aberdeen, UK
Correspondence to:
Correspondence to:
Augusto Azuara Blanco, MD PhD, Ophthalmology Department, Aberdeen Royal Infirmary, The Eye Clinic, Foresterhill, Aberdeen AB25 2ZN, UK;
aazblanco@aol.com
Accepted 13 December 2002
Keywords: Moorens ulcer; campath-1H
| The first 150 words of the full text of this article appear below. |
Moorens ulcer is a rare idiopathic peripheral ulcerative keratitis. The diagnosis is usually based on characteristic clinical features and absence of other causes of peripheral keratitis. The clinical course can be unremitting, particularly in bilateral disease, occasionally leading to total loss of stroma.1,2
An autoimmune process is recognised as being central to the pathogenesis.
Calgranulin-C (CaGC), produced by granulocytes and also expressed by keratocytes, appears to be the target protein for the autoimmune response that leads to Moorens ulcer. Previous corneal trauma2 and a higher prevalence of HLA class II subtypes have been associated with Moorens ulcer.
The disease responds to immunosuppression with variable success. Surgical treatments such as conjunctival recession have been proposed. Campath-1H is a humanised lymphocytotoxic monoclonal antibody (mAb) that targets the CD52 antigen on T lymphocytes. Successful mAb therapy using campath-1H has been reported in serious ophthalmic inflammatory conditions that were unresponsive to maximum conventional immunosuppression.15
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
